Skip to main content

Bomyntra Dosage

Generic name: Denosumab 70mg in 1mL
Dosage form: injection
Drug class: Miscellaneous bone resorption inhibitors

Medically reviewed by Drugs.com. Last updated on Mar 31, 2025.

Important Administration Instructions

Bomyntra should be administered by a healthcare provider.

Bomyntra is intended for subcutaneous route only and should not be administered intravenously, intramuscularly, or intradermally.

Multiple Myeloma and Bone Metastasis from Solid Tumors

The recommended dose of Bomyntra is 120 mg administered as a subcutaneous injection every 4 weeks in the upper arm, upper thigh, or abdomen.

Administer calcium and vitamin D as necessary to treat or prevent hypocalcemia.

Giant Cell Tumor of Bone

The recommended dose of Bomyntra is 120 mg administered every 4 weeks with additional 120 mg doses on Days 8 and 15 of the first month of therapy. Administer subcutaneously in the upper arm, upper thigh, or abdomen.

Administer calcium and vitamin D as necessary to treat or prevent hypocalcemia.

Hypercalcemia of Malignancy

The recommended dose of Bomyntra is 120 mg administered every 4 weeks with additional 120 mg doses on Days 8 and 15 of the first month of therapy. Administer subcutaneously in the upper arm, upper thigh, or abdomen.

Preparation and Administration

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Bomyntra is a clear, colorless to pale yellow solution that is free from visible particles. Do not use if the solution is discolored or cloudy or if the solution contains particles or foreign particulate matter.

Prior to administration, Bomyntra may be removed from the refrigerator and brought to room temperature (up to 25°C/77°F) by standing in the original container. This generally takes 15 to 30 minutes. Do not warm Bomyntra in any other way.

Instructions for Bomyntra Vial

Use a 27-gauge needle to withdraw and inject the entire contents of the vial. Do not re-enter the vial. Discard vial after single entry.

Instructions for Administration of Bomyntra Prefilled Syringe with Needle Safety Guard

IMPORTANT:

In order to minimize accidental needlesticks, the Bomyntra single-dose prefilled syringe has an automatic clear needle safety guard.

Bomyntra prefilled syringe (Before & After use). See figure below.

Figure
Step 1: Remove Needle Cap (see Figure A)
Do not hold the prefilled syringe by the plunger rod.
Do not twist or bend the needle cap.

Figure A
Figure A

Step 2: Administer Subcutaneous Injection
Choose an injection site. The recommended injection sites for Bomyntra include (see Figure B):
  • upper thigh
  • abdomen
  • upper arm
Do not administer into muscle or blood vessel.
Pinch the skin and insert the needle at a 45 to 90-degree
angle. Push the plunger with a slow and constant pressure until you cannot press further and have injected all the
liquid subcutaneously (see Figure C).
You may hear or feel a “click”.

Figure B
Figure B
Figure C
Figure C

Step 3. Release Plunger
Keeping the prefilled syringe at the injection site, slowly release the plunger and lift syringe off the skin. The clear needle guard will automatically cover the needle (see Figure D).

Do not recap the needle.
Immediately dispose of used prefilled syringe into a sharps
disposal container.

Figure D
Figure D

Does Bomyntra interact with my other drugs?

Enter medications to view a detailed interaction report using our Drug Interaction Checker.

Frequently asked questions

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.